Efficacy and Tolerability of Albiglutide Versus Placebo or Pioglitazone Over 1 Year in People With Type 2 Diabetes Currently Taking Metformin and Glimepiride: HARMONY 5
Makimura H, Feldpausch MN, Rope AM, Hemphill LC, Torriani M, Lee H, et al
The regulatory enforcement record on MT-II is dense and international
However, some cutting-edge technologies like PROTACs (proteolysis-targeting chimeras), RNA interference, clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9-based genome editing, and artificial intelligence (AI)-based drug design, allow screening of therapeutics targeting almost all kinds of molecules, like proteins and epigenetic regulators
Drug-related problems among breastfeeding women
10.1016/j.biopha.2020.109847